A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

BACKGROUND: A single-arm phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in the treatment of advanced-stage ovarian cancer has begun in Korea. We hypothesized that adding durvalumab (anti-programmed death-ligand 1 antibody) and tremelimumab (anti-cytotoxic T-lymphocyte-as...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Gynecol Oncol
Main Authors: Lee, Jung-Yun, Kim, Jae Weon, Lim, Myong Cheol, Kim, Sunghoon, Kim, Hee Seung, Choi, Chel Hun, Yi, Ju Yeon, Park, Sang-Yoon, Kim, Byoung-Gie
Format: Artigo
Sprog:Inglês
Udgivet: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Fag:
Clinical Trial Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779618/
https://ncbi.nlm.nih.gov/pubmed/31576697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e112
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker